Takeda concludes sale of select OTC and non-core assets to Hypera Pharma EP News Bureau Jan 31, 2021 This divestment agreement was first announced in March 2020
Elder Pharma launches ‘Solo’ inhalers Usha Sharma Feb 19, 2015 Forays into the Rs 800-crore nasal inhaler segment
